Lauren Migliore
-
Buy One, Get One Free At Charles River Laboratories
By Morningstar : By Lauren Migliore Contract research organizations dramatically cut costs and development time for drugmakers. As cutbacks continue in response to …
-
Top Biotech Acquisition Candidates… M&A environment is biotech analyst Lauren Migliore . Thanks for joining me, Lauren. Lauren Migliore : Good to be here, Karen. Andersen ..... acquirer. Andersen : OK, great. Thanks, Lauren . Migliore : Thanks, Karen. Andersen : So for …
Morningstar. With me today to discuss the M&A environment is biotech analyst Lauren Migliore . Thanks for joining me, Lauren. Lauren Migliore : Good to be here, Karen. Andersen : So, just to recap 2011, it was a relatively light year for biotech M&A.whether they are targeted by an acquirer. Andersen : OK, great. Thanks, Lauren . Migliore : Thanks, Karen. Andersen : So for our full biotech takeout list for 2012, as well as our M&A outlook for other -
Savient Loses CEO to Dendreon Amid Management Shakeup
… ImClone to Eli Lilly LLY in 2008, and we think his appointment could reinvigorate takeover speculation for Dendreon. The firm ranked No. 4 on Morningstar's Biotech Takeover List last year. Lauren Migliore also contributed to this note.
-
Contract Research Organizations Still On Sale As Industry Rebounds
By Morningstar : By Lauren Migliore We think the contract research organization (CRO) industry is on the rebound, as evidenced by a resurgence in new business activity …
-
Gen-Probe: New Tests Key to Increasing RevenueLauren Migliore : My name is Lauren Migliore ; I am a health-care analyst here at Morningstar. Gen ..... re very welcome. Thanks for having me. Migliore : I'm Lauren Migliore for Morningstar. Thanks for joining us.
Lauren Migliore : My name is Lauren Migliore ; I am a health-care analyst here at Morningstar. Gen-Probe is a leading provider of molecular diagnostic products used to diagnose human diseasesWatts : You're very welcome. Thanks for having me. Migliore : I'm Lauren Migliore for Morningstar. Thanks for joining us. -
A CRO Under the MicroscopeLauren Migliore : Hi, my name is Lauren Migliore . I'm a health-care analyst here at Morningstar. Contract ..... Thanks for joining us, Jim. James F. Winschel : Thanks, Lauren . Migliore : Well, let's start off with an overview of the industry …
Lauren Migliore : Hi, my name is Lauren Migliore . I'm a health-care analyst here at Morningstar. Contract research organization Parexel is a leading provider of outsourced research and development services to pharmaceutical and biotechnology companies. With us today is the firm's CFO, Jim Winschel, to speak with us about the competitive landscape in the drug development industry. Thanks for joining us, Jim. James F. Winschel : Thanks, Lauren . Migliore : Well, let's start off with an overview of the industry. Can you outline the benefits that CROs offer over traditional in-houseyour thoughts. Winschel : Okay. Thanks, Lauren. Appreciate it. Migliore : I'm Lauren Migliore for Morningstar. Thanks for joining us. -
Option Spotlight: Keep Your Portfolio Healthy With These Health-Care Picks
… contract research organizations) like Icon are absolutely essential to his business. Here is what Morningstar analyst Lauren Migliore has to say about the firm: "Icon's client-focused operating model and growing scale have helped it gain entrance …
-
Why You Shouldn't Bail On Biotech
By Morningstar : By Lauren Migliore The biotechnology sector has been hit especially hard as investors flee high-risk assets amid recent market uncertainty. Compounding …
-
Personalized Medicine is the FutureLauren Migliore : Hi, my name is Lauren Migliore . I'm a health-care analyst here at Morningstar. Gen ..... comments and for being with us today. Rosenman : Thank you, Lauren . Migliore : I'm Lauren Migliore for Morningstar. Thanks for joining …
Lauren Migliore : Hi, my name is Lauren Migliore . I'm a health-care analyst here at Morningstar. Gen-Probe is a leading provider of molecular diagnostic products used to diagnose human diseases andyour comments and for being with us today. Rosenman : Thank you, Lauren . Migliore : I'm Lauren Migliore for Morningstar. Thanks for joining us. -
Going Global to Ease Drug Trial ProcessLauren Migliore : Contract research organization, Parexel is a leading provider of ..... for being here today. Winschel : Okay. Thank you. Migliore : I'm Lauren Migliore for Morningstar. Thanks for joining us.
Lauren Migliore : Contract research organization, Parexel is a leading provider of outsourced research and development services to pharmaceutical and biotechnology companies. We're pleasedfor being here today. Winschel : Okay. Thank you. Migliore : I'm Lauren Migliore for Morningstar. Thanks for joining us.